Elevated high-density lipoprotein levels following acute graft-versus-host disease onset: a potential link to T-cell dysfunction and increased relapse risk

In this study, lipoprotein profiling* revealed that patients with acute graft-versus-host disease had elevated early post-transplant HDL levels, which were associated with delayed T-cell re-normalisation and increased effector-memory CD8 T-cells, findings mirrored in vitro by HDL-induced reductions in healthy donor T-cell proliferation and activation, suggesting that high HDL may impair graft-versus-leukaemia efficacy through T-cell modulation and thereby increase relapse risk. 

Scroll to Top
video-thumb

Dr. Roland Geyer

COO
10+ years experience in NMR-based metabolomics and diagnostic.

Dr. Renate Kirchhöfer

CDO & Co-Founder
20+ years developing NMR-applications and bringing them to regulated markets.

Dr. Fritz Huber

CEO & Co-Founder
20+ years developing and marketing NMR-based assays—he is a pioneer in this field.

Dr. Ali Tinazli

CEO, lifespin GmbH

15+ years in Fortune 100 corporate strategy and entrepreneurship (SONY, HP).